Replennabis
Carbon Tablet for Alleviating Hangover and Nausea Symptoms
Health Tech & Life Sciences
Non Active, Oct 2021 ceased to operate
Company Overview
Snapshot
Founded in March 2018 by Kayla Berman and Andra Weissberger, Replennabis operates with 1–10 employees. The company is currently in a Pre-Funding stage.
Business overview
Replennabis is a Health Tech & Life Sciences company focused on developing a hangover solution. Its core product is a carbon tablet infused with CBD hemp extract (cannabis sativa L), which is THC-free and non-psychoactive. The solution also contains essential vitamins and minerals designed to help replenish and revitalize the body after excessive drinking, serving both B2B and B2C markets in the pharmaceuticals and consumer goods sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is Replennabis's primary product?
- Replennabis's primary product is a carbon tablet designed to alleviate hangover and nausea symptoms. It is infused with CBD hemp extract (cannabis sativa L), which is THC-free and non-psychoactive, and contains essential vitamins and minerals.
- When was Replennabis founded and by whom?
- Replennabis was founded in March 2018 by Kayla Berman, who serves as Co-founder & CEO, and Andra Weissberger, Co-founder & COO.
- What is the operational status of Replennabis?
- Replennabis ceased to operate in October 2021.
- In which sectors does Replennabis primarily operate?
- Replennabis operates within the Health Tech & Life Sciences sector, specifically focusing on Pharmaceuticals, Medical Cannabis, herbal medicine, and consumer goods.
- What markets does Replennabis target with its products?
- Replennabis targets both B2B and B2C markets with its carbon tablet solution for hangover and nausea relief.